Tom Melvin

Oct 24, 2023 | onlinelibrary.wiley.com | Laura Downey |Shane O'Donnell |Tom Melvin

The recent clearance by the United States Food and Drug Administration (US FDA) of the Tidepool Loop sets an important precedent within the medical device landscape. For the first time, an automated insulin delivery (AID) mobile application – based on an algorithm initially designed and developed by users themselves – has been recognised as safe and effective by a regulatory body.

Oct 24, 2023 | onlinelibrary.wiley.com | Laura Downey |Shane O'Donnell |Tom Melvin

The recent clearance by the United States Food and Drug Administration (US FDA) of the Tidepool Loop sets an important precedent within the medical device landscape. For the first time, an automated insulin delivery (AID) mobile application – based on an algorithm initially designed and developed by users themselves – has been recognised as safe and effective by a regulatory body.

Aug 9, 2023 | politico.eu | Tom Melvin

Press play to listen to this article Voiced by artificial intelligence. Tom Melvin is an associate professor in Medical Device Regulatory Affairs in the School of Medicine, Trinity College Dublin. Many of us have engaged with chatbots, the computerized conversational programs meant to help with things like our banking or a utility company query.

Jan 31, 2023 | nature.com | Tom Melvin

AbstractMobile apps are the primary means by which consumers access digital health and wellness software, with delivery dominated by the ‘Apple App Store’ and the ‘Google Play Store’. Through these virtual storefronts Apple and Google act as the distributor (and sometimes, importer) of many thousands of health and wellness apps into the EU, some of which have a medical purpose.